ENG/中
老虎证券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Cellect Biotechnology Ltd.
13.17
0.0000
成交量:
- -
成交额:
- -
市值:
1,291.23万
市盈率:
-2.56
高:
13.17
开:
13.17
低:
13.17
收:
13.17
52周最高:
35.52
52周最低:
6.88
股本:
98.04万
流通股本:
94.29万
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-5.1505
每股收益(LYR):
-6.1107
净资产收益率:
-120.42%
总资产收益率:
-47.79%
市净率:
8.34
市盈率(LYR):
-2.16
数据加载中...
总览
公司
新闻资讯
公告
2021/03/29
年度报告
20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16
超过5%披露
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13
超过5%披露
SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/04
[修订]年度报告
20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/22
超过5%披露
[Amend] General statement of acquisition of beneficial ownership
2020/04/03
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/03
年度报告
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/02
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/04
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14
超过5%披露
[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/17
超过5%披露
Statement of acquisition of beneficial ownership by individuals
2020/01/10
超过5%披露
Statement of acquisition of beneficial ownership by individuals
2020/01/10
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/08
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/07
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/03
超过5%披露
[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/30
非美公司披露报告
Report of foreign issuer [Rules 13a-16 and 15d-16]
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/APOP/filings"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"APOP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APOP\",,,,,undefined,":{"symbol":"APOP","market":"US","secType":"STK","nameCN":"Cellect Biotechnology Ltd.","latestPrice":13.17,"timestamp":1636142400000,"preClose":13.17,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":942862,"shares":980434,"eps":-5.150534,"marketStatus":"盘后交易","change":0,"latestTime":"02-25 19:45:55 EST","open":13.17,"high":13.17,"low":13.17,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.150534,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1772067600000},"marketStatusCode":4,"adr":0,"adrRate":400,"listingDate":523425600000,"exchange":"NASDAQ","adjPreClose":13.17,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APOP\",,,,,undefined,":{"symbol":"APOP","floatShares":942862,"roa":"-47.79%","roe":"-120.42%","lyrEps":-6.110709,"shares":980434,"dividePrice":0,"high":13.17,"amplitude":0,"preClose":13.17,"low":13.17,"week52Low":6.88,"pbRate":"8.34","week52High":35.52,"institutionHeld":0,"latestPrice":13.17,"eps":-5.150534,"divideRate":0,"volume":0,"delay":0,"ttmEps":-5.150534,"open":13.17,"prevYearClose":8.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APOP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-09-24","symbol":"APOP","defaultRemindTime":1632490200000,"type":"split","dateTimestamp":1632456000000,"forFactor":4,"toFactor":1,"ratio":4},{"market":"US","date":"2021-08-24","symbol":"APOP","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1629777600000,"reportTimeType":"","actualEps":-0.43},{"market":"US","date":"2021-03-29","symbol":"APOP","fiscalQuarterEnding":"2020/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1616990400000,"reportTimeType":"","actualEps":-0.39},{"market":"US","date":"2020-11-20","symbol":"APOP","fiscalQuarterEnding":"2020/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1605848400000,"reportTimeType":"","actualEps":-0.12},{"market":"US","date":"2020-08-12","symbol":"APOP","fiscalQuarterEnding":"2020/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1597204800000,"reportTimeType":"","actualEps":-0.69}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APOP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APOP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APOP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APOP","date":"2021-10-29","current":-2.557016,"percent":0.578313,"low":-18.175493,"twenty":-6.410673,"median":-2.868349,"eighty":-1.428707,"high":-0.746847,"avg":-3.979545,"sd":2.737054,"marketCap":12912315},"quantilePoints":[{"date":"2021-02-26","current":-2.336953,"twenty":-7.06617,"median":-3.92791,"eighty":-1.344969,"marketCap":13448645},{"date":"2021-03-05","current":-1.913999,"twenty":-7.057229,"median":-3.88573,"eighty":-1.34803,"marketCap":10946572},{"date":"2021-03-12","current":-2.289908,"twenty":-7.039707,"median":-3.860295,"eighty":-1.351357,"marketCap":13135886},{"date":"2021-03-19","current":-2.403165,"twenty":-7.027611,"median":-3.804582,"eighty":-1.355689,"marketCap":13878689},{"date":"2021-03-26","current":-3.25897,"twenty":-7.020893,"median":-3.722331,"eighty":-1.359012,"marketCap":18648267},{"date":"2021-04-01","current":-2.260874,"twenty":-7.019392,"median":-3.612174,"eighty":-1.359242,"marketCap":12275798},{"date":"2021-04-09","current":-2.17048,"twenty":-7.018274,"median":-3.58467,"eighty":-1.36216,"marketCap":11923944},{"date":"2021-04-16","current":-1.787263,"twenty":-7.01609,"median":-3.565172,"eighty":-1.373538,"marketCap":9851914},{"date":"2021-04-23","current":-1.654651,"twenty":-7.009871,"median":-3.538081,"eighty":-1.375145,"marketCap":9187301},{"date":"2021-04-30","current":-1.804107,"twenty":-7.007382,"median":-3.526353,"eighty":-1.376341,"marketCap":10047389},{"date":"2021-05-07","current":-1.707825,"twenty":-7.006331,"median":-3.520323,"eighty":-1.378959,"marketCap":9500060},{"date":"2021-05-14","current":-1.821226,"twenty":-6.997555,"median":-3.489178,"eighty":-1.389417,"marketCap":10047389},{"date":"2021-05-21","current":-1.894162,"twenty":-6.974944,"median":-3.475128,"eighty":-1.397221,"marketCap":10516528},{"date":"2021-05-28","current":-2.080504,"twenty":-6.968423,"median":-3.448518,"eighty":-1.405324,"marketCap":11572090},{"date":"2021-06-04","current":-2.305849,"twenty":-6.967002,"median":-3.435334,"eighty":-1.412364,"marketCap":12823127},{"date":"2021-06-11","current":-2.225111,"twenty":-6.944447,"median":-3.411608,"eighty":-1.414381,"marketCap":12353988},{"date":"2021-06-18","current":-2.943759,"twenty":-6.943672,"median":-3.369853,"eighty":-1.420261,"marketCap":16224383},{"date":"2021-06-25","current":-2.553941,"twenty":-6.936173,"median":-3.357588,"eighty":-1.422483,"marketCap":14191448},{"date":"2021-07-02","current":-2.576013,"twenty":-6.931081,"median":-3.337765,"eighty":-1.423118,"marketCap":14230543},{"date":"2021-07-09","current":-2.42572,"twenty":-6.922511,"median":-3.265876,"eighty":-1.423753,"marketCap":13370455},{"date":"2021-07-16","current":-2.931924,"twenty":-6.917015,"median":-3.220969,"eighty":-1.425846,"marketCap":16107098},{"date":"2021-07-23","current":-3.163014,"twenty":-6.909757,"median":-3.175683,"eighty":-1.428011,"marketCap":17475420},{"date":"2021-07-30","current":-3.066532,"twenty":-6.90228,"median":-3.109984,"eighty":-1.431172,"marketCap":17162661},{"date":"2021-08-06","current":-2.880984,"twenty":-6.875578,"median":-2.988079,"eighty":-1.431172,"marketCap":16146193},{"date":"2021-08-13","current":-2.774348,"twenty":-6.839235,"median":-2.926661,"eighty":-1.431172,"marketCap":15598865},{"date":"2021-08-20","current":-2.82369,"twenty":-6.822282,"median":-2.904234,"eighty":-1.431172,"marketCap":15755244},{"date":"2021-08-27","current":-3.141131,"twenty":-6.766824,"median":-2.898002,"eighty":-1.428707,"marketCap":16146193},{"date":"2021-09-03","current":-4.170685,"twenty":-6.72392,"median":-2.898002,"eighty":-1.428707,"marketCap":21569553},{"date":"2021-09-10","current":-4.813592,"twenty":-6.649428,"median":-2.898002,"eighty":-1.428707,"marketCap":24903023},{"date":"2021-09-17","current":-4.812316,"twenty":-6.601998,"median":-2.898002,"eighty":-1.428707,"marketCap":24863806},{"date":"2021-09-24","current":-18.175493,"twenty":-6.571346,"median":-2.898002,"eighty":-1.428707,"marketCap":94121664},{"date":"2021-10-01","current":-3.515209,"twenty":-6.543481,"median":-2.898002,"eighty":-1.428707,"marketCap":18098811},{"date":"2021-10-08","current":-3.440507,"twenty":-6.516789,"median":-2.898002,"eighty":-1.428707,"marketCap":17638007},{"date":"2021-10-15","current":-3.10517,"twenty":-6.468163,"median":-2.898002,"eighty":-1.428707,"marketCap":15971269},{"date":"2021-10-22","current":-2.740991,"twenty":-6.443977,"median":-2.881372,"eighty":-1.428707,"marketCap":14157466},{"date":"2021-10-29","current":-2.463442,"twenty":-6.410673,"median":-2.868349,"eighty":-1.428707,"marketCap":12912315}],"updateTime":1772066755110},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"APOP\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"12912334","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021018137-APOP","pdf_url":null,"pub_time":1616947200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"APOP","title":"20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/0001213900-21-018137-index.htm","us_notice_code":"Form 20-F","us_title_en":"20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f20f2020_cellectbiotech.htm","type":"20-F","id":"NTFILEGYCNzvPZLAaxQSNB","market":"us","size":1836629},{"description":"DESCRIPTION OF SECURITIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex2-5_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex2-5_cellectbio.htm","type":"EX-2.5","id":"NTFILEAWba5wT7nLafzfb7","market":"us","size":123551},{"description":"SUBSIDIARIES OF CELLECT BIOTECHNOLOGY LTD","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex8-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex8-1_cellectbio.htm","type":"EX-8.1","id":"NTFILE2KLRXMyXbfAJyBBA","market":"us","size":2345},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex12-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex12-1_cellectbio.htm","type":"EX-12.1","id":"NTFILE2ogwhgqvUdfz224L","market":"us","size":10645},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex12-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex12-2_cellectbio.htm","type":"EX-12.2","id":"NTFILEHoD9MNxkTW1QApeU","market":"us","size":10610},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex13-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex13-1_cellectbio.htm","type":"EX-13.1","id":"NTFILE7u45xcFzFcXVCkdi","market":"us","size":3021},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex13-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex13-2_cellectbio.htm","type":"EX-13.2","id":"NTFILE2iQwRa1mggRANjEh","market":"us","size":3103},{"description":"CONSENT OF KORST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex15-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex15-1_cellectbio.htm","type":"EX-15.1","id":"NTFILEG7MeLjGAHEKJVjzv","market":"us","size":2087},{"description":"CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO., CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex15-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex15-2_cellectbio.htm","type":"EX-15.2","id":"NTFILE2Pot5qsrsgNNsVGF","market":"us","size":3375},{"description":"CONSENT OF KORST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/f20f2020ex16-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2020ex16-1_cellectbio.htm","type":"EX-16.1","id":"NTFILEDqmoh2J2k63PX8rk","market":"us","size":1839},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILE4KPVL4oBDrscWU7C","market":"us","size":76684},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/img_002.jpg","primary":false,"translateUrl":null,"linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILE5t8V6vzTMWYWfdcA","market":"us","size":10853},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/img_003.jpg","primary":false,"translateUrl":null,"linkName":"img_003.jpg","type":"GRAPHIC","id":"NTFILEFA6knBrZVycZMWua","market":"us","size":6959},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/ex15-2_001.jpg","primary":false,"translateUrl":null,"linkName":"ex15-2_001.jpg","type":"GRAPHIC","id":"NTFILE6TPJYn693SG5DxCG","market":"us","size":3995},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390021018137/ex15-2_002.jpg","primary":false,"translateUrl":null,"linkName":"ex15-2_002.jpg","type":"GRAPHIC","id":"NTFILEFXMhJGVd26kuFEFY","market":"us","size":7848}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2021-03-29 00:00","pubTimestamp":1616947200,"title_zh":"20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12912322","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465921023190-APOP","pdf_url":null,"pub_time":1613404800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","symbol":"APOP","title":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465921023190/0001104659-21-023190-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1649553/000110465921023190/tm216476d3_sc13ga.htm","primary":true,"translateUrl":null,"linkName":"tm216476d3_sc13ga.htm","type":"SC 13G/A","id":"NTFILEHh1nA38G6fWUk2vw","market":"us","size":71539}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2021-02-16 00:00","pubTimestamp":1613404800,"title_zh":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12912323","market":"us","labels":[],"media":"sec.gov","original_id":"AN90266421000169-APOP","pdf_url":null,"pub_time":1610467200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"APOP","title":"SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000090266421000169/0000902664-21-000169-index.htm","us_notice_code":"Form SC 13G","us_title_en":"SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CELLECT BIOTECHNOLOGY LTD.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1469336/000090266421000169/p21-0081sc13g.htm","primary":true,"translateUrl":null,"linkName":"p21-0081sc13g.htm","type":"SC 13G","id":"NTFILEZNYyaZuHRMeCfMKM","market":"us","size":74417}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2021-01-13 00:00","pubTimestamp":1610467200,"title_zh":"SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10221303","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020020139-APOP","pdf_url":null,"pub_time":1596470400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"APOP","title":"20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"[修订]年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020020139/0001213900-20-020139-index.htm","us_notice_code":"Form 20-F/A","us_title_en":"20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO FORM 20-F","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020020139/f20f2019a1_cellectbio.htm","primary":true,"translateUrl":null,"linkName":"f20f2019a1_cellectbio.htm","type":"20-F/A","id":"NTFILEEa6Q6R5GqbGcKesh","market":"us","size":50185},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020020139/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILE5B7yDX33knwG6Tud","market":"us","size":10493},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020020139/img_002.jpg","primary":false,"translateUrl":null,"linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILEHEazHGJ8UwwhMxvn","market":"us","size":10149}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"[Rev.]Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"[修订]年度报告","pubTime":"2020-08-04 00:00","pubTimestamp":1596470400,"title_zh":"20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9571575","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020009811-APOP","pdf_url":null,"pub_time":1587484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Amend] General statement of acquisition of beneficial ownership","symbol":"APOP","title":"[Amend] General statement of acquisition of beneficial ownership","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020009811/0001213900-20-009811-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 2 TO SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020009811/ea120945-13da2yarkoni_cellec.htm","primary":true,"translateUrl":null,"linkName":"ea120945-13da2yarkoni_cellec.htm","type":"SC 13D/A","id":"NTFILE41GuPKL5kwqZvsYk","market":"us","size":37120}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2020-04-22 00:00","pubTimestamp":1587484800,"title_zh":"Amend] General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9413044","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020008495-APOP","pdf_url":null,"pub_time":1585843200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008495/0001213900-20-008495-index.htm","us_notice_code":"Form 6-K","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CELLECT BIOTECHNOLOGY REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008495/ea120287ex99-1_cellect.htm","primary":true,"translateUrl":null,"linkName":"ea120287ex99-1_cellect.htm","type":"EX-99.1","id":"NTFILE7itBBYH9d6A9Qpc3","market":"us","size":154033},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008495/ea120287-6k_cellectbiotech.htm","primary":false,"translateUrl":null,"linkName":"ea120287-6k_cellectbiotech.htm","type":"6-K","id":"NTFILEHVkkugZgnAn4VUux","market":"us","size":14225},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008495/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEGNtHfio5eqBWTZSS","market":"us","size":1927}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-04-03 00:00","pubTimestamp":1585843200,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9412972","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020008493-APOP","pdf_url":null,"pub_time":1585843200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"APOP","title":"Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/0001213900-20-008493-index.htm","us_notice_code":"Form 20-F","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f20f2019_cellectbiotech.htm","type":"20-F","id":"NTFILEC6jAz15UzjhV2dsL","market":"us","size":2539465},{"description":"DESCRIPTION OF SECURITIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex2-5_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex2-5_cellectbio.htm","type":"EX-2.5","id":"NTFILEGgmnkKFfhq4i5njf","market":"us","size":122435},{"description":"SUBSIDIARIES OF CELLECT BIOTECHNOLOGY LTD.","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex8-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex8-1_cellectbio.htm","type":"EX-8.1","id":"NTFILE9Vx4XepptyAD5JZt","market":"us","size":2304},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex12-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex12-1_cellectbio.htm","type":"EX-12.1","id":"NTFILE8PfvpVSqBrWsqRdo","market":"us","size":10559},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex12-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex12-2_cellectbio.htm","type":"EX-12.2","id":"NTFILEFGMFcWF5E7opwN63","market":"us","size":10593},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex13-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex13-1_cellectbio.htm","type":"EX-13.1","id":"NTFILEAZG47tF3p3avpi2x","market":"us","size":3023},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex13-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex13-2_cellectbio.htm","type":"EX-13.2","id":"NTFILEDLsPbjAtrLrGRqs5","market":"us","size":3027},{"description":"CONSENT OF KORST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex15-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex15-1_cellectbio.htm","type":"EX-15.1","id":"NTFILEFqZXr1feo7qqwmod","market":"us","size":3166},{"description":"CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO., CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex15-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex15-2_cellectbio.htm","type":"EX-15.2","id":"NTFILE3cBjYVcGpFbuxVPW","market":"us","size":3113},{"description":"CONSENT OF KORST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/f20f2019ex16-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex16-1_cellectbio.htm","type":"EX-16.1","id":"NTFILE4XGCUAU5Jm5TK2X4","market":"us","size":2970},{"description":"XBRL INSTANCE FILE","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/apop-20191231.xml","primary":false,"translateUrl":null,"linkName":"apop-20191231.xml","type":"EX-101.INS","id":"NTFILE136B6CU6XTMNUxFS","market":"us","size":1415161},{"description":"XBRL SCHEMA FILE","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/apop-20191231.xsd","primary":false,"translateUrl":null,"linkName":"apop-20191231.xsd","type":"EX-101.SCH","id":"NTFILE6mS4wC2Wgmgti7pu","market":"us","size":87463},{"description":"XBRL CALCULATION FILE","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/apop-20191231_cal.xml","primary":false,"translateUrl":null,"linkName":"apop-20191231_cal.xml","type":"EX-101.CAL","id":"NTFILE3mi6XKGPymcytwZg","market":"us","size":29843},{"description":"XBRL DEFINITION FILE","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/apop-20191231_def.xml","primary":false,"translateUrl":null,"linkName":"apop-20191231_def.xml","type":"EX-101.DEF","id":"NTFILER8PsoRiRDgnLfCvE","market":"us","size":234432},{"description":"XBRL LABEL FILE","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/apop-20191231_lab.xml","primary":false,"translateUrl":null,"linkName":"apop-20191231_lab.xml","type":"EX-101.LAB","id":"NTFILEGPtbpWAvkbvY4vDZ","market":"us","size":478670},{"description":"XBRL PRESENTATION FILE","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/apop-20191231_pre.xml","primary":false,"translateUrl":null,"linkName":"apop-20191231_pre.xml","type":"EX-101.PRE","id":"NTFILE3WDL6fjsfUkiwdyJ","market":"us","size":239693},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILE7o36eGVvKqpBSPZ8","market":"us","size":75616},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/img_002.jpg","primary":false,"translateUrl":null,"linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILE71zuUdUL5twMWER3","market":"us","size":79756},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/fin_001.jpg","primary":false,"translateUrl":null,"linkName":"fin_001.jpg","type":"GRAPHIC","id":"NTFILE7RccLZxsVYZFmjch","market":"us","size":10655},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008493/ex15-2.jpg","primary":false,"translateUrl":null,"linkName":"ex15-2.jpg","type":"GRAPHIC","id":"NTFILE4gmkxjSwE3FxjRNF","market":"us","size":3995}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2020-04-03 00:00","pubTimestamp":1585843200,"title_zh":"Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9407007","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020008412-APOP","pdf_url":null,"pub_time":1585756800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008412/0001213900-20-008412-index.htm","us_notice_code":"Form 6-K","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CELLECT BIOTECHNOLOGY RECEIVES NEW PATENT ALLOWANCE IN CHINA","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008412/ea120314ex99-1_cellect.htm","primary":true,"translateUrl":null,"linkName":"ea120314ex99-1_cellect.htm","type":"EX-99.1","id":"NTFILE9dYfz8nWnNyAeZMn","market":"us","size":9748},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020008412/ea120314-6k_cellect.htm","primary":false,"translateUrl":null,"linkName":"ea120314-6k_cellect.htm","type":"6-K","id":"NTFILE45sbzajcX9hqfWcH","market":"us","size":13227}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-04-02 00:00","pubTimestamp":1585756800,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9158861","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020005359-APOP","pdf_url":null,"pub_time":1583251200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020005359/0001213900-20-005359-index.htm","us_notice_code":"Form 6-K","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CELLECT BIOTECHNOLOGY AND CANNDOC LTD. TO ENTER INTO STRATEGI PHARMA GRADE CANNA","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020005359/ea119242ex99-1_cellectbio.htm","primary":true,"translateUrl":null,"linkName":"ea119242ex99-1_cellectbio.htm","type":"EX-99.1","id":"NTFILE2BT9JBLx8Ckqggso","market":"us","size":21115},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020005359/ea119242-6k_cellectbiotech.htm","primary":false,"translateUrl":null,"linkName":"ea119242-6k_cellectbiotech.htm","type":"6-K","id":"NTFILE5A1VDXRVRxAK8Fe3","market":"us","size":12670},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020005359/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE95PHDdsdkZcHZ9jd","market":"us","size":6439},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020005359/ex99-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILE6Gw6w2PBbe2kqBLH","market":"us","size":11258},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020005359/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEEYzTFcDkenSvFPZA","market":"us","size":4982}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-03-04 00:00","pubTimestamp":1583251200,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9099349","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312520038322-APOP","pdf_url":null,"pub_time":1581609600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Amend] Statement of acquisition of beneficial ownership by individuals","symbol":"APOP","title":"[Amend] Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000119312520038322/0001193125-20-038322-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"[Amend] Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1491072/000119312520038322/d891716dsc13ga.htm","primary":true,"translateUrl":null,"linkName":"d891716dsc13ga.htm","type":"SC 13G/A","id":"NTFILEDjGiXjBrrL5auyq8","market":"us","size":119288}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2020-02-14 00:00","pubTimestamp":1581609600,"title_zh":"Amend] Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9027658","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020001905-APOP","pdf_url":null,"pub_time":1580054400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/0001213900-20-001905-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/f6k012720_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f6k012720_cellectbiotech.htm","type":"6-K","id":"NTFILEGrkmrW1sMbZ7b1db","market":"us","size":14715},{"description":"NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S SPECIAL GENERAL MEETING","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/f6k012720ex99-1_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f6k012720ex99-1_cellectbio.htm","type":"EX-99.1","id":"NTFILEAoddsJx9QbHvSQkC","market":"us","size":42322},{"description":"PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S SPECIAL","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/f6k012720ex99-2_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f6k012720ex99-2_cellectbio.htm","type":"EX-99.2","id":"NTFILE2jW7ZSZSXQnyeLVA","market":"us","size":13968},{"description":"VOTING INSTRUCTION CARD FOR HOLDERS OF THE COMPANYS ADS HOLDERS WITH RESPECT TO","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/f6k012720ex99-3_cellectbio.htm","primary":false,"translateUrl":null,"linkName":"f6k012720ex99-3_cellectbio.htm","type":"EX-99.3","id":"NTFILE5NsHez1zJQTUD6N1","market":"us","size":1425},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE4b9zfGnYEAyJRcHH","market":"us","size":5257},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/ex99-2_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-2_001.jpg","type":"GRAPHIC","id":"NTFILEJDfbppA9zgTpdN4d","market":"us","size":5289},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/proxy_001.jpg","primary":false,"translateUrl":null,"linkName":"proxy_001.jpg","type":"GRAPHIC","id":"NTFILE8uBVqs5uc8fthPEk","market":"us","size":64038},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020001905/proxy_002.jpg","primary":false,"translateUrl":null,"linkName":"proxy_002.jpg","type":"GRAPHIC","id":"NTFILEEXQAcae47EKeGNjG","market":"us","size":70159}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-01-27 00:00","pubTimestamp":1580054400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9004353","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465920004930-APOP","pdf_url":null,"pub_time":1579190400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Statement of acquisition of beneficial ownership by individuals","symbol":"APOP","title":"Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465920004930/0001104659-20-004930-index.htm","us_notice_code":"Form SC 13G","us_title_en":"Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1649553/000110465920004930/a20-3412_1sc13g.htm","primary":true,"translateUrl":null,"linkName":"a20-3412_1sc13g.htm","type":"SC 13G","id":"NTFILE5ayNJNSXCJ2hUyPd","market":"us","size":102698}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2020-01-17 00:00","pubTimestamp":1579190400,"title_zh":"Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8984124","market":"us","labels":[],"media":"sec.gov","original_id":"AN90266420000160-APOP","pdf_url":null,"pub_time":1578585600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Statement of acquisition of beneficial ownership by individuals","symbol":"APOP","title":"Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000090266420000160/0000902664-20-000160-index.htm","us_notice_code":"Form SC 13G","us_title_en":"Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CELLECT BIOTECHNOLOGY LTD.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1469336/000090266420000160/p20-0099sc13g.htm","primary":true,"translateUrl":null,"linkName":"p20-0099sc13g.htm","type":"SC 13G","id":"NTFILEDK78unNt9UkrJe1i","market":"us","size":80411}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2020-01-10 00:00","pubTimestamp":1578585600,"title_zh":"Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8983708","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020000726-APOP","pdf_url":null,"pub_time":1578585600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000726/0001213900-20-000726-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 6-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000726/f6k010920c_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f6k010920c_cellectbiotech.htm","type":"6-K","id":"NTFILEFuULvjypTNATojLm","market":"us","size":7406}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-01-10 00:00","pubTimestamp":1578585600,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8983705","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020000724-APOP","pdf_url":null,"pub_time":1578585600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000724/0001213900-20-000724-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000724/f6k010820b_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f6k010820b_cellectbiotech.htm","type":"6-K","id":"NTFILEB2qw3JvwMMqAnCYF","market":"us","size":26867},{"description":"OPINION OF DORON TIKOTZKY KANTOR GUTMAN & AMIT GROSS","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000724/f6k010820bex5-1_cellect.htm","primary":false,"translateUrl":null,"linkName":"f6k010820bex5-1_cellect.htm","type":"EX-5.1","id":"NTFILE8dpmSAFcVxpRPg3A","market":"us","size":25374},{"description":"FORM OF SECURITIES PURCHASE AGREEMENT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000724/f6k010820bex10-1_cellect.htm","primary":false,"translateUrl":null,"linkName":"f6k010820bex10-1_cellect.htm","type":"EX-10.1","id":"NTFILE9Gm19djoFJcvaMSu","market":"us","size":187880},{"description":"PLACEMENT AGENT AGREEMENT DATED JANUARY 7, 2020","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000724/f6k010820bex10-2_cellect.htm","primary":false,"translateUrl":null,"linkName":"f6k010820bex10-2_cellect.htm","type":"EX-10.2","id":"NTFILE6khNHJGNdcQRFqiW","market":"us","size":55074},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000724/ex5-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEAyCcGcfQUQ9FCqyE","market":"us","size":19328}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-01-10 00:00","pubTimestamp":1578585600,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8976902","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020000459-APOP","pdf_url":null,"pub_time":1578412800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000459/0001213900-20-000459-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE, DATED JANUARY 8, 2020","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000459/f6k010820ex99-1_cellect.htm","primary":true,"translateUrl":null,"linkName":"f6k010820ex99-1_cellect.htm","type":"EX-99.1","id":"NTFILE8fKTQbWTUggDotQS","market":"us","size":11739},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000459/f6k010820_cellectbiotech.htm","primary":false,"translateUrl":null,"linkName":"f6k010820_cellectbiotech.htm","type":"6-K","id":"NTFILEGcsfBJRN9JqxAq63","market":"us","size":10949}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-01-08 00:00","pubTimestamp":1578412800,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8972619","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020000322-APOP","pdf_url":null,"pub_time":1578326400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000322/0001213900-20-000322-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE, DATED JANUARY 7, 2020","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000322/f6k010720bex99-1_cellect.htm","primary":true,"translateUrl":null,"linkName":"f6k010720bex99-1_cellect.htm","type":"EX-99.1","id":"NTFILE3HM3hSk5jXssJd1c","market":"us","size":17150},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000322/f6k010720b_cellectbiotech.htm","primary":false,"translateUrl":null,"linkName":"f6k010720b_cellectbiotech.htm","type":"6-K","id":"NTFILE4EdhzrfxzWiiAKVg","market":"us","size":16041},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000322/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEHpoQTBMUECuvfU4r","market":"us","size":4141}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-01-07 00:00","pubTimestamp":1578326400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8968539","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020000253-APOP","pdf_url":null,"pub_time":1578240000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000253/0001213900-20-000253-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390020000253/f6k010620a_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f6k010620a_cellectbiotech.htm","type":"6-K","id":"NTFILECQgKxBEoyPXEMHm9","market":"us","size":12349}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2020-01-06 00:00","pubTimestamp":1578240000,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8960888","market":"us","labels":[],"media":"sec.gov","original_id":"AN153561020000009-APOP","pdf_url":null,"pub_time":1577980800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Amend] Statement of acquisition of beneficial ownership by individuals","symbol":"APOP","title":"[Amend] Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000153561020000009/0001535610-20-000009-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"[Amend] Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SABBY 13G-A APOP 1.03.20","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1535610/000153561020000009/apop0120.txt","primary":true,"translateUrl":null,"linkName":"apop0120.txt","type":"SC 13G/A","id":"NTFILEG6SbRZa7Z8qjX7g2","market":"us","size":13473}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2020-01-03 00:00","pubTimestamp":1577980800,"title_zh":"Amend] Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8924572","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019027135-APOP","pdf_url":null,"pub_time":1577635200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"APOP","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露报告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1671502/000121390019027135/0001213900-19-027135-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000121390019027135/f6k123019_cellectbiotech.htm","primary":true,"translateUrl":null,"linkName":"f6k123019_cellectbiotech.htm","type":"6-K","id":"NTFILE6sgK8A2EpYJwzLZs","market":"us","size":10333}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露报告","pubTime":"2019-12-30 00:00","pubTimestamp":1577635200,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":163,"code":"91000000","status":"200"}]}}